APA (7th ed.) Citation

FJG, v. A., CM, d. M., JM, S., C, M., PJ, v. D., PJ, N., . . . TJA, v. N. (2024). Disease extent according to baseline [18F]fluorodeoxyglucose PET/CT and molecular subtype: Prediction of axillary treatment response after neoadjuvant systemic therapy for breast cancer. The British journal of surgery, 111(9), . https://doi.org/10.1093/bjs/znae203

Chicago Style (17th ed.) Citation

FJG, van Amstel, et al. "Disease Extent According to Baseline [18F]fluorodeoxyglucose PET/CT and Molecular Subtype: Prediction of Axillary Treatment Response After Neoadjuvant Systemic Therapy for Breast Cancer." The British Journal of Surgery 111, no. 9 (2024). https://doi.org/10.1093/bjs/znae203.

MLA (9th ed.) Citation

FJG, van Amstel, et al. "Disease Extent According to Baseline [18F]fluorodeoxyglucose PET/CT and Molecular Subtype: Prediction of Axillary Treatment Response After Neoadjuvant Systemic Therapy for Breast Cancer." The British Journal of Surgery, vol. 111, no. 9, 2024, https://doi.org/10.1093/bjs/znae203.